A Clinical Trial to study the effect of Kokilaksha Extract in the management of Iron Deficiency Anaemia
- Conditions
- Health Condition 1: D508- Other iron deficiency anemias
- Registration Number
- CTRI/2024/04/065535
- Lead Sponsor
- Principal Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients fulfilling the diagnostic criteria of Iron Deficiency Anemia.
a. Based on Symptoms
b. Hemoglobin less than 130gm/L in males, less than 120gm/L in Females, less than 110gm/L in pregnancy.
c. Sr. Ferritin Reduced, Male:24 to 336ng/L, Female:24 to 336ng/L.
d. TIBC Raised 262 to 474mcg/dl.
e. Sr. Iron Reduced, women:26 to 170, Men:76 to 198.
f. MCV Low 80-100 Femtolitre.
g. Mentzer’s index - greater than 13 Iron Deficiency anemia.
2. Patients belonging to age group of 18 -60 years (both inclusive) of either sex irrespective of religion, socio economic status, etc.
3. Patient willing and able to participate in the study.
1. Patients with history of congenital disorders related with haemopoietic system like SCA, Leukemia & hemophilia.
2. Patients with history of other systemic diseases like uncontrolled diabetes mellitus and hypertension.
3. Patients suffering from disorder of the GIT system associated with Gastrointestinal bleeding like colorectal malignancy, gastritis, peptic ulceration & inflammatory bowel disease.
4. Patients on chronic use of aspirin & NSAIDS.
5. Pregnant & lactating women.
6. Immunocompromised Patients-HIV.
7. Patients on prolonged medication (more than 6 weeks) with corticosteroids, or any other drugs that may have influence on the outcome of the study.
8. Patients who are currently participating in any other clinical trials (since last 2 months).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method